Albany, NY -- (SBWire) -- 11/20/2018 --ResearchMoz.us has announced the addition of a report, titled "Regulatory Affairs Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018–2026". The study on the global regulatory affairs outsourcing market offers elaborate assessment of the trends and developments impacting the current outlook and prospects of the regulatory affairs outsourcing market. It offers in-depth insights into the prevailing regulatory landscape, related advances in pharmaceutical industry, key clinical developments, and promising avenues in various regions.
The evolution of the regulatory affairs outsourcing market is driven by the rising need for increasing the return on investment by businesses in the life science industries across the world. In various countries, the intensifying need for reducing the cost of prescription drugs, against the backdrop of dwindling research and development (R&D) spending, has propelled a growing number of pharmaceutical companies outsource their regulatory affairs.
The global regulatory affairs outsourcing market is projected to rise at a promising, double-digit CAGR from 2018 to 2026. The rising cost of regulatory compliance, coupled with the rising need for speedy approval of products, has led biopharmaceutical and medical device companies in various parts of the world increasingly adopt regulatory affairs outsourcing.
Get a Sample PDF: https://www.researchmoz.us/enquiry.php?type=S&repid=1927535
The increasingly complex regulatory environments has led several companies in the life sciences industries to prefer outsourcing over in-house management of regulatory affairs. The paucity of technical expertise in drug manufacturing and clinical testing, coupled with stringent regional regulatory frameworks, in developing and developed nations, has led many companies to resort to outsourcing of regulatory affairs.
The growing need to obtain quicker returns from research and development activities by biopharmaceutical companies in emerging markets is also fueling the demand for regulatory affairs outsourcing services. The market is also benefitting from the growing number of imminent patent expirations in numerous countries. The rising demand for regulatory writing and publishing for clinical trial summaries and medical writing is also boosting the regulatory affairs outsourcing market.
The regulatory affairs outsourcing market is receiving robust impetus from the staggering rise in number of clinical trials in developed regions, notably in the U.S. Regionally, the substantial rise in R&D spending in the life sciences industries in North America over the past few years is also helping the regional market to expand steadily. On the other hand, Asia Pacific is expected to rise at increasingly promising CAGR during 2018–2026. Rising number of pharmaceutical companies focusing their attentions in Asia Pacific also makes this regional market increasingly attractive.
Top players in the regulatory affairs outsourcing market are focusing on acquisitions and are engaging in strategic collaborations, in order to consolidate their shares over the coming years. Some of the prominent players operating in the regulatory affairs outsourcing market are Dr. Regenold GmbH, BlueReg Group, ICON plc., Promedica International, Criterium, Inc., Clinilabs Inc., Accell Clinical Research LLC, and IQVIA.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Focus on Improving Return on Investment by Life Science Industries Boost Regulatory Affairs Outsourcing Market